Hepatic failure | 30 | Valproate 21, vigabatrin 2, lamotrigine, phenobarbitone, primadone, polypharmacy 4 (carbamazepine 4, valproate 2, lamotrigine, vigabatrin) |
Epilepsy | 5 | Gabapentin, lorazepam, trimethadione, polypharmacy 2 (topiramate 2, diazepam, lamotrigine, phenytoin, vigabatrin) |
Bone marrow suppression | 5 | Carbamazepine 2, ethosuximide, polypharmacy (carbamazepine, valproate, topiramate, pheneturide, phenobarbitone, primadone) |
Hepatic and renal failure | 4 | Carbamazepine, valproate, topiramate, polypharmacy (lamotrigine, paraldehyde) |
Unexplained | 8 | Vigabatrin 3, topiramate 2, carbamazepine, lamotrigine, valproate |
Stevens-Johnson syndrome | 2 | Phenytoin 2 |
Respiratory arrest | 1 | Diazepam 1 |
Sepsis | 1 | Lamotrigine |
Disseminated intravascular coagulation | 2 | Lamotrigine, valproate |
Cerebral tumour | 1 | Polypharmacy (carbamazepine, topiramate) |
Pancreatitis | 1 | Valproate |
Gastrointestinal haemorrhage | 1 | Carbamazepine |
Pulmonary oedema | 1 | Valproate |
Abdominal malignancy | 1 | Valproate |
Epidermal necrolysis | 1 | Valproate |
Withdrawal seizure | 1 | Vigabatrin |
| | |
Total | 65 | |